COMPLETED

Evaluation of the Acceptability and Feasibility of a Bedtime Routine for Neonates

Talk to us

Conditions

Newborn

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to assess, via caregiver questionnaire, the acceptability and feasibility of implementing a bedtime routine for newborns.

Official Title

A Clinical Evaluation of the Acceptability and Feasibility to Caregivers of a Bedtime Routine for Neonates

Quick Facts

Study Start:2024-04-18
Study Completion:2025-08-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT06318637

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:2 Weeks
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Full term at birth (gestational age greater than or equal to \[\>=\] 37 weeks)
  2. * A singleton birth. (Having other infants/children in the household will be allowed but only 1 child per household may be enrolled)
  3. * Breastfed, formula-fed, or combination
  4. * Able to read, write, speak, and understand English
  5. * Must be the parent (biological or adoptive) and legal guardian of the infant participant who is willing and able to present proof of legal guardianship (example: birth certificate/hospital discharge paperwork along with valid ID of legal guardian, etc.)
  1. * Has known allergies or adverse reactions to common topical skincare products or the ingredients in the investigational study materials
  2. * Has a history of or a concurrent health condition/situation which, in the opinion of the Principal Investigator (PI) or Study Physician, may put the individual at significant risk, confound the study results, or interfere significantly with the individual's participation in the study
  3. * Is simultaneously participating in any other clinical study or has participated in a clinical study since infant's birth
  4. * Is an employee/contractor or immediate family member of the PI, Study Site, or Sponsor
  5. * Presents with a skin condition that may influence the outcome of the study (specifically psoriasis, eczema, atopic dermatitis, or erythema)

Contacts and Locations

Principal Investigator

Nancy Rodgers, Ph.D.
PRINCIPAL_INVESTIGATOR
SGS North America, Inc.

Study Locations (Sites)

SGS North America, Inc.
Richardson, Texas, 75081
United States

Collaborators and Investigators

Sponsor: Johnson & Johnson Consumer Inc. (J&JCI)

  • Nancy Rodgers, Ph.D., PRINCIPAL_INVESTIGATOR, SGS North America, Inc.

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-04-18
Study Completion Date2025-08-12

Study Record Updates

Study Start Date2024-04-18
Study Completion Date2025-08-12

Terms related to this study

Additional Relevant MeSH Terms

  • Newborn